- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Mar 11, 2026
353267F00133P7YFR-MF-0000140731 warning recorded — scroll inside the panel to see all entries.
CW010Primary placement in France; available across 17 countries total.
| Country | On market since | Until |
|---|---|---|
| FrancePrimary placement | May 29, 2024 | Still on market |
| Austria | May 29, 2024 | Still on market |
| Belgium | May 29, 2024 | Still on market |
| Cyprus | May 29, 2024 | Still on market |
| Germany | May 29, 2024 | Still on market |
| EL | May 29, 2024 | Still on market |
| Spain | May 29, 2024 | Still on market |
| Ireland | May 29, 2024 | Still on market |
| Italy | May 29, 2024 | Still on market |
| Liechtenstein | May 29, 2024 | Still on market |
| Luxembourg | May 29, 2024 | Still on market |
| Malta | May 29, 2024 | Still on market |
| Netherlands | May 29, 2024 | Still on market |
| Norway | May 29, 2024 | Still on market |
| Poland | May 29, 2024 | Still on market |
| Portugal | May 29, 2024 | Still on market |
| Slovenia | May 29, 2024 | Still on market |
W0105011607BORDETELLA PERTUSSIS / PARAPERTUSSIS - NA REAGENTSCertificate health across this manufacturer's portfolio.
030/MDRIssuedG10 002187 0009Issued